NEW YORK, April 2 - Lion Bioscience has licensed its SRS bioinformatics platform to Incyte Genomics for three years, the German company said on Tuesday.

Financial terms of the deal were not disclosed, but Lion said it expects to pocket annual license fees and royalties from Incyte as well as from those Incyte customers that use the SRS-based software platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers examine the gap in funding between researchers and research institutions, ScienceInsider reports

By sequencing two ancient dog genomes, researchers from the US and Germany suggest that dogs were domesticated in a single event, the Washington Post reports.

In Genome Research this week: population dynamics of E. coli infection, lncRNA expression changes in macaque aging, and more.

Noninvasive prenatal testing can uncover pregnancies at risk of miscarriage, New Scientist reports.